PuriCore Investment Thesis
- Critical need for safe, effective, natural solutions to control the spread of infectious pathogens.
- Scientifically proven. Intellectually protected.
- Significant share and leadership already in core markets.
- Leverageable platform technology and competencies.
- Strong revenue and margin growth in predictable model.
Latest Announcements
Information on this page is updated via a feed from the London Stock Exchange's Regulatory News Service.
- 02/07/08 - Awarded Contract
- 01/07/08 - Patent Decision and Debt Financing
- 26/06/08 - AGM Statement
15 minute delayed prices from the London Stock Exchange provided by Hemscott Group Limited.
